| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8271952 | Journal of Geriatric Oncology | 2018 | 7 Pages |
Abstract
Low chemotherapy preference prior to treatment initiation was associated with lower QoL, worse physical symptoms and self-rated function and more adverse events mid-treatment. There is no association of chemotherapy preference with survival.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Ageing
Authors
Ajeet Gajra, Linda McCall, Hyman B. Muss, Harvey J. Cohen, Aminah Jatoi, Karla V. Ballman, Ann H. Partridge, Linda Sutton, Barbara A. Parker, Gustav Magrinat, Heidi D. Klepin, Jacqueline M. Lafky, Arti Hurria,